Jiangsu Apon Medical Technology Co., Ltd.
Символ: 300753.SZ
SHZ
12.14
CNYПазарна цена днес
-88.2145
Съотношение P/E
0.0000
Коефициент PEG
1.53B
MRK Cap
- 0.00%
Доходност на DIV
Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 775.8 | 249.3 | 274.7 | 388.6 | |||||||||
balance-sheet.row.short-term-investments | 230.28 | -22.7 | -7.6 | -1.5 | |||||||||
balance-sheet.row.net-receivables | 636.91 | 133.6 | 139.2 | 102.3 | |||||||||
balance-sheet.row.inventory | 254.77 | 61 | 67.4 | 31.7 | |||||||||
balance-sheet.row.other-current-assets | 9.03 | 1.5 | 2.9 | 0.7 | |||||||||
balance-sheet.row.total-current-assets | 1676.5 | 445.4 | 484.2 | 523.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 834.02 | 207 | 212.8 | 168.6 | |||||||||
balance-sheet.row.goodwill | 212.97 | 53.2 | 69.4 | 33.9 | |||||||||
balance-sheet.row.intangible-assets | 140.12 | 35.6 | 33.2 | 37.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 353.08 | 88.8 | 102.6 | 71.6 | |||||||||
balance-sheet.row.long-term-investments | 81.26 | 103.8 | 87 | 60.5 | |||||||||
balance-sheet.row.tax-assets | 96.58 | 24.4 | 8.7 | 2.1 | |||||||||
balance-sheet.row.other-non-current-assets | 317.43 | 0.8 | 3.7 | 1.2 | |||||||||
balance-sheet.row.total-non-current-assets | 1682.37 | 424.8 | 414.9 | 303.9 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 3358.87 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.account-payables | 118.76 | 46.9 | 27.8 | 31.4 | |||||||||
balance-sheet.row.short-term-debt | 156.26 | 33.8 | 2 | -3.4 | |||||||||
balance-sheet.row.tax-payables | 19.87 | 6.6 | 8.5 | 14.5 | |||||||||
balance-sheet.row.long-term-debt-total | 132.88 | 34.5 | 39.9 | 3.7 | |||||||||
Deferred Revenue Non Current | 7.47 | 1.9 | 2 | 2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.11 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 3.7 | 1.6 | 42.3 | 53.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 141.46 | 36.7 | 42 | 2.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 132.88 | 34.5 | 39.9 | 3.7 | |||||||||
balance-sheet.row.total-liab | 599.68 | 183.9 | 118.5 | 87.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 504.19 | 126 | 126 | 105 | |||||||||
balance-sheet.row.retained-earnings | 765.2 | 188.1 | 264.5 | 247.1 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 825.9 | 41.5 | 41.5 | 36.5 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 659.81 | 329.9 | 347.6 | 350.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 2755.1 | 685.6 | 779.6 | 739.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3358.87 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.minority-interest | 4.08 | 0.8 | 0.9 | 0.3 | |||||||||
balance-sheet.row.total-equity | 2759.18 | 686.4 | 780.5 | 739.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3358.87 | - | - | - | |||||||||
Total Investments | 311.54 | 81.1 | 79.4 | 59 | |||||||||
balance-sheet.row.total-debt | 289.14 | 68.4 | 39.9 | 3.7 | |||||||||
balance-sheet.row.net-debt | -233.66 | -180.9 | -234.8 | -384.8 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -17.35 | -76.5 | 53.3 | 96.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 17.55 | 19.6 | 15.4 | 9.7 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 15.5 | 6.6 | -0.7 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 28.3 | -76.7 | -25.8 | |||||||||
cash-flows.row.account-receivables | 0 | 9.1 | -47.6 | -34 | |||||||||
cash-flows.row.inventory | 0 | 6.3 | -33.6 | -3.3 | |||||||||
cash-flows.row.account-payables | 0 | 28.4 | 11.1 | 10.7 | |||||||||
cash-flows.row.other-working-capital | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.other-non-cash-items | -7.54 | 4.1 | 26.3 | 2.6 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -7.34 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -26.24 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.acquisitions-net | 0.08 | 0.1 | -37.3 | 2.7 | |||||||||
cash-flows.row.purchases-of-investments | -260 | -3 | -22.5 | -52.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 271.04 | 259 | 0.1 | 0.8 | |||||||||
cash-flows.row.other-investing-activites | -20.31 | -256.7 | 2.5 | 1.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | -35.43 | -24.8 | -96.7 | -83.1 | |||||||||
cash-flows.row.debt-repayment | -29.4 | -29.4 | 0 | -0.4 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | -1.28 | -0.6 | -31.5 | -32.3 | |||||||||
cash-flows.row.other-financing-activites | 32.24 | 54 | -4.3 | 0.4 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 1.56 | 23.9 | -35.8 | -32.3 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -2.31 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | -43.52 | -25.5 | -114.3 | -32 | |||||||||
cash-flows.row.cash-at-end-of-period | 522.3 | 248.8 | 274.3 | 388.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 565.81 | 274.3 | 388.6 | 420.6 | |||||||||
cash-flows.row.operating-cash-flow | -7.34 | -24.6 | 18.3 | 83.3 | |||||||||
cash-flows.row.capital-expenditure | -26.24 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.free-cash-flow | -33.58 | -48.8 | -21.3 | 47.7 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 405.24 | 323.8 | 461.2 | 443.1 | |||||||||
income-statement-row.row.cost-of-revenue | 175.27 | 163.8 | 166.3 | 188.6 | |||||||||
income-statement-row.row.gross-profit | 229.97 | 160 | 294.9 | 254.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 29.94 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 24.02 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 152.61 | - | - | - | |||||||||
income-statement-row.row.other-expenses | -1.77 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.operating-expenses | 236.09 | 232 | 235.5 | 146.3 | |||||||||
income-statement-row.row.cost-and-expenses | 411.36 | 395.7 | 401.8 | 334.9 | |||||||||
income-statement-row.row.interest-income | 3 | 2.1 | 3.6 | 7.2 | |||||||||
income-statement-row.row.interest-expense | 3.12 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 152.61 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | -1.77 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | -1.77 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.total-operating-expenses | -1.77 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.interest-expense | 3.12 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 18.92 | 19.6 | 15.4 | 9.7 | |||||||||
income-statement-row.row.ebitda-caps | -5.7 | - | - | - | |||||||||
income-statement-row.row.operating-income | -24.62 | -88.3 | 55.8 | 113.5 | |||||||||
income-statement-row.row.income-before-tax | -26.38 | -90.7 | 55.3 | 111.9 | |||||||||
income-statement-row.row.income-tax-expense | -11.05 | -14.2 | 2 | 15 | |||||||||
income-statement-row.row.net-income | -17.35 | -76.4 | 54.1 | 97 |
Често задавани въпроси
Какво е Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) общи активи?
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) общите активи са 870213234.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 201746617.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.266.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.266.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.043.
Какъв е общият приход на предприятието?
Общият приход е -0.061.
Каква е Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -76377405.540.
Какъв е общият дълг на фирмата?
Общият дълг е 68373296.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 231973871.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 110977030.000.